Analysts See $1.41 EPS for ICON Public Limited Company (ICLR); NEXANS PARIS ORDINARY SHARES (NXPRF) Shorts Decreased By 3.25%

March 22, 2018 - By Michael Collier

Analysts expect ICON Public Limited Company (NASDAQ:ICLR) to report $1.41 EPS on April, 26.They anticipate $0.12 EPS change or 9.30% from last quarter’s $1.29 EPS. ICLR’s profit would be $76.26 million giving it 20.94 P/E if the $1.41 EPS is correct. After having $1.43 EPS previously, ICON Public Limited Company’s analysts see -1.40% EPS growth. The stock decreased 1.32% or $1.575 during the last trading session, reaching $118.115. About 11,118 shares traded. ICON Public Limited Company (NASDAQ:ICLR) has risen 40.78% since March 22, 2017 and is uptrending. It has outperformed by 24.08% the S&P500.

NEXANS PARIS ORDINARY SHARES (OTCMKTS:NXPRF) had a decrease of 3.25% in short interest. NXPRF’s SI was 11,900 shares in March as released by FINRA. Its down 3.25% from 12,300 shares previously. With 100 avg volume, 119 days are for NEXANS PARIS ORDINARY SHARES (OTCMKTS:NXPRF)’s short sellers to cover NXPRF’s short positions. The SI to NEXANS PARIS ORDINARY SHARES’s float is 0.05%. The stock 0.32% or $0 during the last trading session, reaching $53.77. It is down 0.00% since March 22, 2017 and is . It has underperformed by 16.70% the S&P500.

Nexans S.A. provides cables and cabling solutions worldwide. The company has market cap of $2.36 billion. It operates through three divisions: Transmission, Distribution & Operators; Industry; and Distributors & Installers. It has a 16.08 P/E ratio. The firm offers low, medium, and high-voltage power cables, as well as related accessories; copper and optical fiber cables; underwater cables; and harnesses and industrial, and equipment cables.

Among 12 analysts covering Icon plc (NASDAQ:ICLR), 8 have Buy rating, 1 Sell and 3 Hold. Therefore 67% are positive. Icon plc had 39 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of ICON Public Limited Company (NASDAQ:ICLR) has “Buy” rating given on Monday, October 9 by Jefferies. The stock has “Buy” rating by SunTrust on Monday, July 31. The rating was reinitiated by Credit Suisse with “Outperform” on Friday, August 14. The rating was maintained by Credit Suisse on Monday, October 16 with “Buy”. Suntrust Robinson downgraded ICON Public Limited Company (NASDAQ:ICLR) on Friday, December 16 to “Hold” rating. The company was maintained on Thursday, February 15 by Robert W. Baird. The rating was initiated by Credit Suisse on Tuesday, June 21 with “Outperform”. The stock has “Buy” rating by Jefferies on Thursday, June 29. The firm has “Market Perform” rating given on Wednesday, October 21 by Avondale. On Thursday, February 15 the stock rating was maintained by Jefferies with “Buy”.

ICON Public Limited Company, a contract research organization, provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. The company has market cap of $6.39 billion. The firm specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It has a 23.02 P/E ratio. The Company’s clinical development services comprise product development planning, strategic consulting, study protocol preparation, clinical pharmacology, pharmacokinetic and pharmacodynamic analysis, clinical research center, investigator site, patient recruitment, study monitoring and data collection, case report form preparation, statistical analysis, patient safety and risk monitoring, clinical data management, strategic analysis and data operation, regulatory consulting, and medical reporting and pharmacovigilance services.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Posts